Duygu Kuzuoglu Ozturk

Assistant Prof

Sabancı University
Country flagTurkey

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (10)

Selective inhibition of mRNA translation is a promising strategy for modulating the activity of disease-associated genes, yet achieving both high potency and specificity remains challenging. Rocaglamide A (RocA), a molecular glue, inhibits translation by clamping eIF4A onto polypurine motifs found in many transcripts, thereby limiting RocA’s specificity. Here, we developed RocASO, a chemical conjugate that links RocA to an antisense oligonucleotide (ASO) capable of base-pairing with defined mRNA sequences, thus directing RocA’s clamping mechanism to chosen targets and enhancing overall potency and specificity. We show that RocASOs are compatible with various types of ASO modalities, including gapmers that induce the degradation of target RNAs. RocASOs were designed to effectively knock down endogenous genes ( PTGES3 , HSPA1B ) and SARS-CoV-2 viral RNA, the latter conferring potent antiviral activity in cells. These findings establish RocASO as a versatile platform for programmable translational inhibition with therapeutic potential.

Year:

2025

Supplementary Figure 6 shows clinical data analysis of neoadjuvant androgen axis inhibition in primary prostate cancer as well as expression analysis of AR, MHCI, and IFNG activity in mHSPC clinical samples.

Year:

2025

Year:

2025

Supplementary Figure 6 shows clinical data analysis of neoadjuvant androgen axis inhibition in primary prostate cancer as well as expression analysis of AR, MHCI, and IFNG activity in mHSPC clinical samples.

Year:

2025

Year:

2025

Tumors escape immune detection and elimination through a variety of mechanisms. Here, we used prostate cancer as a model to examine how androgen-dependent tumors undergo immune evasion through downregulation of the major histocompatibility complex class I (MHCI). We report that response to immunotherapy in late-stage prostate cancer is associated with elevated MHC expression. To uncover the mechanism, we performed a genome-wide CRISPR interference (CRISPRi) screen and identified androgen receptor ( AR ) as a repressor of the MHCI pathway. Syngeneic mouse models of aggressive prostate cancer deficient in Ar also demonstrated increased tumor immunogenicity and promoted T cell–mediated tumor control. Notably, the increase in MHCI expression upon AR blockade is transient and correlates with resistance to AR inhibition. Mechanistic studies identified androgen response elements upstream of MHCI transcription start sites which increased MHCI expression when deleted. Together, this body of work highlights another mechanism by which hormones can promote immune escape. Significance: Immunotherapy options for immune cold tumors, like prostate cancer, are limited. We show that AR downregulates MHCI expression/antigen presentation and that AR inhibition improves T-cell responses and tumor control. This suggests that treatments combining AR inhibitors and checkpoint blockade may improve tumor immune surveillance and antitumor immunity in patients.

Year:

2025

Deregulation of neuroblastoma-derived myc (N-myc) is a leading cause of malignant brain tumors in children. To target N-myc-driven medulloblastoma, most research has focused on identifying genomic alterations or on the analysis of the medulloblastoma transcriptome. Here, we have broadly characterized the translatome of medulloblastoma and shown that N-myc unexpectedly drives selective translation of transcripts that promote protein homeostasis. Cancer cells are constantly exposed to proteotoxic stress associated with alterations in protein production or folding. It remains poorly understood how cancers cope with proteotoxic stress to promote their growth. Here, our data revealed that N-myc regulates the expression of specific components (∼5%) of the protein folding machinery at the translational level through the major cap binding protein, eukaryotic initiation factor eIF4E. Reducing eIF4E levels in mouse models of medulloblastoma blocked tumorigenesis. Importantly, targeting Hsp70, a protein folding chaperone translationally regulated by N-myc, suppressed tumor growth in mouse and human medulloblastoma xenograft models. These findings reveal a previously hidden molecular program that promotes medulloblastoma formation and identify new therapies that may have impact in the clinic. Significance: Translatome analysis in medulloblastoma shows that N-myc drives selective translation of transcripts that promote protein homeostasis and that represent new therapeutic vulnerabilities.

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Collaborators (26)

Thomas O'Loughlin

Icahn School of Medicine at Mount Sinai

UNITED STATES
View details

Davide Ruggero

Professor

University of California

UNITED STATES
View details

Nevan Krogan

Professor

University of California, San Francisco

UNITED STATES
View details

David A. Quigley

Assistant Professor

University of California, San Francisco

UNITED STATES
View details

Wilbert Zwart

Senior Groupleader / professor

Eindhoven University of Technology

NETHERLANDS
View details

Robert Wechsler-Reya

Professor

Columbia University Irving Medical Center

UNITED STATES
View details

Luke Gilbert

Assistant Professor

University of California, San Francisco

UNITED STATES
View details

Alan Ashworth

University of California, San Francisco

UNITED STATES
View details

Zheng Xia

Associate Professor

University of Texas at Austin

UNITED STATES
View details

Adam Sowalsky

Senior Investigator

National Cancer Institute

UNITED STATES
View details

Michelle Badura

Lecturer

Santa Clara University

UNITED STATES
View details

Danielle Swaney

University of California, San Francisco

UNITED STATES
View details

Raunak Shrestha

Assistant Professor

Uniformed Services University of the Health Sciences

UNITED STATES
View details

Lawrence Fong

Fred Hutch Cancer Center

UNITED STATES
View details

Matthew R. Cooperberg

University of California

UNITED STATES
View details

Arian Lundberg

Assistant Professor at KTH Royal Institute of Technology

KTH Royal Institute of Technology

SWEDEN
View details

Jason E. Gestwicki

Professor

University of California, San Francisco

UNITED STATES
View details

Felix Y. Feng

University of California

UNITED STATES
View details

Melanie Ott

Professor

University of California, San Francisco

UNITED STATES
View details

Miller Huang

Assistant Professor

University of Southern California

UNITED STATES
View details

Joanna Kovalski

Assistant Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Joanna J. Phillips

Profesor

University of California, San Francisco

UNITED STATES
View details

Kevan Shokat

Professor

UCSF Medical Center

UNITED STATES
View details

Jessica Hawley

Assistant Professor

University of Washington

UNITED STATES
View details

Maria Barna

Stanford University School of Medicine

UNITED STATES
View details

William A. Weiss

Director of outpatient child neurology

University of California

UNITED STATES
View details